CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19. Issue 6 (December 2022)

• Record Type: Journal Article
• Authors: Gregersen, Ida; Ueland, Thor; Holter, Jan Cato; Olsen, Maria Belland; Michelsen, Annika E; Murphy, Sarah L; Tveita, Anders Aune; Henriksen, Katerina Nezvalova; Hoel, Hedda; Nordberg, Lena Bugge; Holten, Aleksander Rygh; Edvardsen, Thor; Yang, Kuan; Heggelund, Lars; Trøseid, Marius; Müller, Fredrik; Kildal, Anders Benjamin; Dyrhol-Riise, Anne Ma; Barratt-Due, Andreas; Dahl, Tuva B; Aukrust, Pål; Halvorsen, Bente
• Is Part Of: Journal of infection. Volume 85:Issue 6(2022)
• Page Start: 702
• Page End: 769
• Publication Date: 2022-12
• Subjects: Infection -- SARS-CoV-2 -- Heart -- Severity -- Chemokines; Infection -- Periodicals; Bacterial Infections -- Periodicals; Communicable Diseases -- Periodicals; Electronic journals; 616.905
• DOI: 10.1016/j.jinf.2022.09.029
• Languages: English
• ISSNs: 0163-4453

Abstract

Highlights: CXCL16 correlates to severity of Covid-19. CXCL16 associates with cardiac risk markers. CXCL16 predicts risk of 60 days mortality.